DK2332986T3 - Antistof som binder til H-1 parvovirus - Google Patents
Antistof som binder til H-1 parvovirusInfo
- Publication number
- DK2332986T3 DK2332986T3 DK09015373.5T DK09015373T DK2332986T3 DK 2332986 T3 DK2332986 T3 DK 2332986T3 DK 09015373 T DK09015373 T DK 09015373T DK 2332986 T3 DK2332986 T3 DK 2332986T3
- Authority
- DK
- Denmark
- Prior art keywords
- parvovirus
- binds
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/015—Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09015373.5A EP2332986B1 (en) | 2009-12-11 | 2009-12-11 | Antibody that binds to H-1 parvovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2332986T3 true DK2332986T3 (da) | 2013-12-16 |
Family
ID=42072902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09015373.5T DK2332986T3 (da) | 2009-12-11 | 2009-12-11 | Antistof som binder til H-1 parvovirus |
Country Status (8)
Country | Link |
---|---|
US (1) | US8828400B2 (da) |
EP (2) | EP2332986B1 (da) |
JP (1) | JP5755239B2 (da) |
AU (1) | AU2010330349B2 (da) |
CA (1) | CA2781796C (da) |
DK (1) | DK2332986T3 (da) |
ES (1) | ES2438774T3 (da) |
WO (1) | WO2011069614A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2451844T3 (da) | 2009-07-10 | 2015-07-27 | Innate Pharma | Tlr3-bindingsmidler |
ES2438774T3 (es) * | 2009-12-11 | 2014-01-20 | Deutsches Krebsforschungszentrum | Anticuerpo que se une a parvovirus H-1 |
MX361773B (es) | 2012-05-31 | 2018-12-17 | Innate Pharma | Agentes de ligación a tlr3. |
EP3108892A1 (en) * | 2015-06-23 | 2016-12-28 | Deutsches Krebsforschungszentrum | Parvovirus formulation for treating tumors |
WO2016206807A1 (en) | 2015-06-23 | 2016-12-29 | Deutsches Krebsforschungszentrum | Method for large scale production and purification of parvovirus |
CN109627331B (zh) * | 2019-01-22 | 2022-03-29 | 长春西诺生物科技有限公司 | 一种抗犬细小病毒抗体的重链、轻链可变区及基因工程抗体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994010294A1 (en) | 1992-10-23 | 1994-05-11 | New York University | Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
ES2438774T3 (es) * | 2009-12-11 | 2014-01-20 | Deutsches Krebsforschungszentrum | Anticuerpo que se une a parvovirus H-1 |
-
2009
- 2009-12-11 ES ES09015373.5T patent/ES2438774T3/es active Active
- 2009-12-11 EP EP09015373.5A patent/EP2332986B1/en active Active
- 2009-12-11 DK DK09015373.5T patent/DK2332986T3/da active
-
2010
- 2010-12-01 CA CA2781796A patent/CA2781796C/en active Active
- 2010-12-01 US US13/513,502 patent/US8828400B2/en active Active
- 2010-12-01 AU AU2010330349A patent/AU2010330349B2/en active Active
- 2010-12-01 JP JP2012542386A patent/JP5755239B2/ja active Active
- 2010-12-01 WO PCT/EP2010/007301 patent/WO2011069614A1/en active Application Filing
- 2010-12-01 EP EP10803562A patent/EP2509998A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US8828400B2 (en) | 2014-09-09 |
AU2010330349A1 (en) | 2012-06-28 |
CA2781796C (en) | 2016-02-02 |
EP2509998A1 (en) | 2012-10-17 |
EP2332986B1 (en) | 2013-10-09 |
WO2011069614A1 (en) | 2011-06-16 |
JP2013513358A (ja) | 2013-04-22 |
ES2438774T3 (es) | 2014-01-20 |
US20130028913A1 (en) | 2013-01-31 |
CA2781796A1 (en) | 2011-06-16 |
EP2332986A1 (en) | 2011-06-15 |
AU2010330349B2 (en) | 2013-09-19 |
JP5755239B2 (ja) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019004I2 (el) | Τροποποιημενα αντισωματα αντι-ιl-23ρ19 | |
LTC2579894I2 (lt) | CGRP antikūnai | |
SMT201700083B (it) | Anticorpi monoclonali | |
BRPI0907237A2 (pt) | Anticorpo anti-cldn6 | |
BRPI0923359A2 (pt) | Anticorpos anti-igf | |
BRPI0907532A2 (pt) | Anticorpos anti-c5ar humanizados | |
BRPI0916973A2 (pt) | anticorpos para ccr2 | |
BRPI0906877A2 (pt) | Anticorpos anti-trkb aperfeiçoados | |
BRPI1011005A2 (pt) | anticorpos anti-epcam | |
CO7020875A2 (es) | Anticuerpos humanizados que reconocen la alfa-sinucleina | |
BRPI0917204A2 (pt) | variantes estruturais de anticorpos para melhores características terapêuticas | |
BR112012030311A2 (pt) | anticorpo | |
CR20170001A (es) | Anticuerpos anti factor d humanizados | |
BR112013016917A2 (pt) | ligantes que ligam receptor de tgf-beta ii. | |
BRPI0819165A2 (pt) | Anticorpos anti-vegf | |
BRPI1011145A2 (pt) | anticorpo anti-axl | |
BRPI1010297A2 (pt) | anticorpos biespecíficos trivalentes. | |
BRPI0914763A2 (pt) | composição aglutinante | |
BRPI1014262A2 (pt) | anticorpos específicos para caderina-17 | |
BRPI0814111A2 (pt) | Anticorpo monoclonal citotóxico anticâncer | |
CR10705A (es) | Anticuerpos para linfotoxina-alfa | |
BRPI0817427A2 (pt) | Anticorpo anti-bst2 | |
DK3360571T3 (da) | Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid | |
BRPI0909633A2 (pt) | anticorpos anti-tyrp1 | |
DE112010000691A5 (de) | Chromatographievorrichtung |